137 related articles for article (PubMed ID: 81809)
1. Antitumor activity of mycobacterial glycolipid A1.
Reggiardo Z
Infect Immun; 1978 Sep; 21(3):914-7. PubMed ID: 81809
[TBL] [Abstract][Full Text] [Related]
2. Granulomagenic activity of serologically active glycolipids from Mycobacterium bovis BCG.
Reggiardo Z; Shamsuddin AK
Infect Immun; 1976 Dec; 14(6):1369-74. PubMed ID: 826485
[TBL] [Abstract][Full Text] [Related]
3. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y
Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
[TBL] [Abstract][Full Text] [Related]
4. A 64 kDa protein from Mycobacterium bovis BCG shares the same antigenic determinants with line 10 hepatoma cells and has anti-line 10 tumor activity.
Ahsan CR; Sasaki J
FEBS Lett; 1991 Aug; 288(1-2):77-80. PubMed ID: 1715293
[TBL] [Abstract][Full Text] [Related]
5. Trehalose dimycolate elicits eosinophilic skin hypersensitivity in mycobacteria-infected guinea pigs.
Otsuka A; Matsunaga I; Komori T; Tomita K; Toda Y; Manabe T; Miyachi Y; Sugita M
J Immunol; 2008 Dec; 181(12):8528-33. PubMed ID: 19050271
[TBL] [Abstract][Full Text] [Related]
6. Plasma-dependent chemotaxis of macrophages toward BCG cell walls and the mycobacterial glycolipid P3.
Kelly MT
Infect Immun; 1977 Jan; 15(1):180-3. PubMed ID: 319056
[TBL] [Abstract][Full Text] [Related]
7. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
Minden P; Mathews HL
Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.
Yarkoni E; Rapp HJ
Infect Immun; 1980 Jun; 28(3):887-92. PubMed ID: 6995326
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
Yarkoni E; Rapp HJ
Oncology; 1982; 39(5):314-8. PubMed ID: 7099513
[TBL] [Abstract][Full Text] [Related]
10. Monitoring immunotherapy with serologically active glycolipid fractions of BCG.
Wile AG; Reggiardo Z; Sparks FC; Morton DL
Surg Forum; 1976; 27(62):105-5. PubMed ID: 798321
[No Abstract] [Full Text] [Related]
11. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
Kataoka T; Tokunaga T; Murohashi T
J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
[TBL] [Abstract][Full Text] [Related]
12. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
[No Abstract] [Full Text] [Related]
13. INFLUENCE OF EXTRACTION OF 'BOUND WAX D' OF BCG WITH TRICHLOROACETIC ACID ON ITS ADJUVANT ACTIVITY ON DEVELOPMENT OF A DELAYED TYPE OF HYPERSENSITIVITY.
KOTANI S; KITAURA T; HASHIMOTO S; CHIMORI M; KISHIDA H
Biken J; 1964 Jan; 6():321-4. PubMed ID: 14186827
[No Abstract] [Full Text] [Related]
14. Augmentation of immunity of line 10 hepatoma by BCG: comparison of different BCG preparations.
Bartlett GL; Kreider JW; Purnell DM; Katsilas DC
Cancer; 1980 Aug; 46(3):488-96. PubMed ID: 6994867
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
[TBL] [Abstract][Full Text] [Related]
16. Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration.
Yarkoni E; Meltzer MS; Rapp HJ
Int J Cancer; 1977 Jun; 19(6):818-21. PubMed ID: 326683
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. II. Influence of the local inflammatory response on immune reactivity.
Key ME; Hanna MG
J Natl Cancer Inst; 1981 Oct; 67(4):863-9. PubMed ID: 6944553
[TBL] [Abstract][Full Text] [Related]
18. The Mycobacterium bovis BCG 64-kDa surface protein is antigenically shared with different mouse tumor cells and has anti-tumor activity in immunized mice.
Ahsan CR; Sasaki J
Immunol Lett; 1993 Jun; 36(3):235-8. PubMed ID: 7690342
[TBL] [Abstract][Full Text] [Related]
19. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
Azuma I; Yamamura Y
Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
[No Abstract] [Full Text] [Related]
20. Immunotherapy with nonviable microbial components.
Ribi E; Milner KC; Granger DL; Kelly MT; Yamamoto K; Brehmer W; Parker R; Smith RF; Strain SM
Ann N Y Acad Sci; 1976; 277(00):228-38. PubMed ID: 187099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
